Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Barter

Showing results (1-10 of 78) with videos related to

Pageof 8
Sort By:
Endocrinology and Metabolism Clinics of North America|May 26, 2004
Metabolic abnormalities: high-density lipoproteinsPhilip Barter
Atherosclerosis. Supplements|April 13, 2005
The inflammation: lipoprotein cyclePhilip Barter
Atherosclerosis. Supplements|July 11, 2006
Managing diabetic dyslipidaemia--beyond LDL-C:HDL-C and triglyceridesPhilip Barter
Atherosclerosis. Supplements|December 14, 2011
HDL-C: role as a risk modifierPhilip Barter
Arteriosclerosis, Thrombosis, and Vascular Biology|July 16, 2002
Effects of inflammation on high-density lipoproteinsPhilip Barter
Clinical and Experimental Nephrology|September 21, 2013
Lipoprotein metabolism and CKD: overviewPhilip Barter
Atherosclerosis. Supplements|May 4, 2004
HDL: a recipe for longevityPhilip Barter
Current Controlled Trials in Cardiovascular Medicine|January 25, 2002
Anti-atherogenic effects of fibrates in type 2 diabetesPhilip Barter
Atherosclerosis. Supplements|January 26, 2012
Raising HDL-C can be achieved by both lifestyle changes and pharmacological means. IntroductionPhilip Barter
European Heart Journal|November 6, 2009
Australia's Heart Research Institute: a remarkable institution in the southern hemisphere. Interviewed by Iona MacDonaldPhilip Barter
Pageof 8

Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
Endocrinology and Metabolism Clinics of North America|May 26, 2004
Metabolic abnormalities: high-density lipoproteinsPhilip Barter
Atherosclerosis. Supplements|April 13, 2005
The inflammation: lipoprotein cyclePhilip Barter
Atherosclerosis. Supplements|July 11, 2006
Managing diabetic dyslipidaemia--beyond LDL-C:HDL-C and triglyceridesPhilip Barter
Atherosclerosis. Supplements|December 14, 2011
HDL-C: role as a risk modifierPhilip Barter
Arteriosclerosis, Thrombosis, and Vascular Biology|July 16, 2002
Effects of inflammation on high-density lipoproteinsPhilip Barter
Clinical and Experimental Nephrology|September 21, 2013
Lipoprotein metabolism and CKD: overviewPhilip Barter
Atherosclerosis. Supplements|May 4, 2004
HDL: a recipe for longevityPhilip Barter
Current Controlled Trials in Cardiovascular Medicine|January 25, 2002
Anti-atherogenic effects of fibrates in type 2 diabetesPhilip Barter
Atherosclerosis. Supplements|January 26, 2012
Raising HDL-C can be achieved by both lifestyle changes and pharmacological means. IntroductionPhilip Barter
European Heart Journal|November 6, 2009
Australia's Heart Research Institute: a remarkable institution in the southern hemisphere. Interviewed by Iona MacDonaldPhilip Barter
Pageof 8